Rivastigmine Capsules in Patients With Probable Vascular Dementia

Clinical trial NCT00130338 · COMPLETED

Trial details

NCT number: NCT00130338
Sponsor: Novartis
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Vascular Dementia

Start date: 2002-02-01
Primary completion: 2006-05-01
Enrollment: 521

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.